MGF causes downregulation of matrix metallopeptidase 2 (MMP‐2) and matrix metallopeptidase 9 (MMP‐9), which result in decreased cellular proliferation (progression) and tumor motility; these processes ultimately lead to an increase in body weight (Zeng et al., 2020). The gene discussed is MMP2; the disease is neoplasm.